Growing Cluster Headache Therapeutics Market Driven by Rising Adoption of Novel, Pipeline Drugs . Currently there are no cures for Cluster Headaches Fuels Growth but treatments aim to reduce attack frequency and manage pain when attacks occur. The most common therapeutics include triptans like sumatriptan and ergot alkaloids like ergotamine. Key players operating in the cluster headache therapeutics market are Eli Lilly and Company, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries Ltd., and others. Eli Lilly's Emgality was the first FDA-approved preventive treatment specifically indicated for cluster headache in 2019. The Cluster Headache Market Challenges And Opportunities have a relatively low prevalence rate but the pain associated with attacks can severely impact quality of life. Population-level trends show an increasing diagnosis rate in western countries Get More Insights: Cluster Headache Treatments Market (https://www.trendingwebwire.com/cluster-headache-market-trends-size-and-share-analysis/ )